/
/
/

Nectar Lifesciences Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)12.15
Volume (₹)2.75 L
High (₹)12.65
Upper Circuit12.92
Low (₹)12.10
Lower Circuit11.70
Prev Close12.31
52W High (₹)22.40
Price12.22
52W Low (₹)9.30

Share Market Cap & Key Ratios Overview

M.Cap (₹)238.36 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.00
Price to Book0.31
Book Value29.98
EPS (TTM)-12.61
Face Value1.00
ROE (%)-7.46

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
NECLIFENSE
LTP
1W Low
1W High
Market cap (₹)
1916-4 (-0.21%)
1905
1984.80
4,63,791Cr
9250+11 (0.12%)
9087
9467
2,45,081Cr
4905.5-144.5 (-2.86%)
4886.50
5066
1,90,351Cr
1143-48 (-4.03%)
1130.50
1187
1,14,833Cr
1394.7-28.8 (-2.02%)
1389.40
1426.10
1,14,163Cr
1868.5-70 (-3.61%)
1811.70
1949
1,00,660Cr
2132-39.5 (-1.82%)
2132
2192
98,431Cr
2368.8-14.1 (-0.59%)
2341.20
2419.20
98,305Cr
1155-23 (-1.95%)
1154.40
1179.90
96,906Cr
1637.3-8 (-0.49%)
1626.60
1717
95,300Cr
12.22-0.25 (-2.00%)
11.66
12.93
238Cr

Key Highlights of Nectar Lifesciences Ltd Balance Sheet

Nectar Lifesciences Ltd balance sheet discloses shareholders' funds of ₹19.43Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹19.43Cr, and the reserves and surplus of the company is ₹562.88Cr.

The company has its non-current liabilities with total liabilities of ₹388.08Cr as of 2026-03-31.

The current liabilities are ₹25.97Cr as of 2026-03-31. At the same time, current assets are ₹249.57Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹49.3Lakh and tangible assets of ₹3.45Cr, provided in the Nectar Lifesciences Ltd financial statements.